(Q40357100)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28125767%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

title

Peptide Paratope Mimics of the Broadly Neutralizing HIV-1 Antibody b12 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28125767%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28125767%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

author name string

Christina Haußner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28125767%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Dominik Damm

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28125767%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Sandra Nirschl

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28125767%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Anette Rohrhofer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28125767%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Barbara Schmidt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28125767%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

publication date

6 March 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28125767%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28125767%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28125767%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28125767%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

page(s)

647-653

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28125767%20AND%20SRC:MED&resulttype=core&format=json

Antibody responses to envelope glycoproteins in HIV-1 infection

9 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Aptamers, antibody scFv, and antibody Fab' fragments: An overview and comparison of three of the most versatile biosensor biorecognition elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Nanobody-based products as research and diagnostic tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Engineered protein scaffolds as next-generation antibody therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Binding of CDR-derived peptides is mechanistically different from that of high-affinity parental antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

A complementarity-determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Peptides as protein binding site mimetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Synthetic Peptides as Protein Mimics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Enhancement and induction of HIV-1 infection through an assembled peptide derived from the CD4 binding site of gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Ligand selectivity of a synthetic CXCR4 mimetic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Structural definition of a conserved neutralization epitope on HIV-1 gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Transmembrane domain membrane proximal external region but not surface unit-directed broadly neutralizing HIV-1 antibodies can restrict dendritic cell-mediated HIV-1 trans-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

21 January 2018

Tissue sulfhydryl groups

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201600621

21 January 2018

Identifiers

DOI

10.1002/CBIC.201600621

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28125767%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference